These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1365821)

  • 21. Hypertension in insulin-dependent diabetes.
    Norgaard K
    Dan Med Bull; 1996 Feb; 43(1):21-38. PubMed ID: 8906979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etiology, diagnosis, and prevention of renal involvement in insulin-dependent diabetes mellitus.
    Chiumello G; Beccaria L; Meschi F; Mistura L; Brambilla P; Bognetti E
    Pediatrician; 1983-1985; 12(4):199-207. PubMed ID: 6400450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of antihypertensive treatment with indapamide in patients with noninsulin-dependent diabetes and persistent microalbuminuria.
    Gambardella S; Frontoni S; Grazia Felici M; Spallone V; Gargiulo P; Morano S; Menzinger G
    Am J Cardiol; 1990 May; 65(17):46H-50H. PubMed ID: 2330907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H; Blohmé G; Grände B; Björck S
    Nephrol Dial Transplant; 1998 Mar; 13(3):651-5. PubMed ID: 9550642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High blood pressure is a major factor in progression of diabetic nephropathy.
    Parving HH; Hommel E
    J Diabet Complications; 1988; 2(2):92-5. PubMed ID: 2971078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The management of diabetic proteinuria. Which antihypertensive agent?
    Cooper ME; Doyle AE
    Drugs Aging; 1992; 2(4):301-9. PubMed ID: 1504444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Microalbuminuria in prediction and prevention of diabetic nephropathy in insulin-dependent diabetes mellitus patients.
    Mogensen CE
    J Diabetes Complications; 1995; 9(4):337-49. PubMed ID: 8573761
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N; Babazono T; Takagi M; Yoshida N; Toya K; Nyumura I; Hanai K; Uchigata Y
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current therapeutic management of diabetic nephropathy.
    Kohler SM; Krämer BK
    Acta Diabetol; 1994 Sep; 31(3):119-25. PubMed ID: 7827347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in understanding mechanisms and natural history of diabetic renal disease.
    Viberti G
    Diabetes Care; 1988; 11 Suppl 1():3-9. PubMed ID: 3069389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How to protect the kidney in diabetic patients: with special reference to IDDM.
    Mogensen CE
    Diabetes; 1997 Sep; 46 Suppl 2():S104-11. PubMed ID: 9285510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The kidney in diabetes: how to control renal and related cardiovascular complications.
    Mogensen CE
    Am J Kidney Dis; 2001 Jan; 37(1 Suppl 2):S2-6. PubMed ID: 11158852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patterns of renal injury in NIDDM patients with microalbuminuria.
    Fioretto P; Mauer M; Brocco E; Velussi M; Frigato F; Muollo B; Sambataro M; Abaterusso C; Baggio B; Crepaldi G; Nosadini R
    Diabetologia; 1996 Dec; 39(12):1569-76. PubMed ID: 8960844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy.
    Holdaas H; Hartmann A; Berg KJ; Langberg H; Blystad L; Fauchald P
    J Intern Med; 1995 Jan; 237(1):63-71. PubMed ID: 7830033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1998 Jan; 16(1):S99-101. PubMed ID: 9534107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diabetic renal disease: microalbuminuria, implications and intervention.
    Savage MW; Leese GP; Vora JP
    Nutrition; 1995; 11(6):761-4. PubMed ID: 8719137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can glomerular mRNAs in human type 1 diabetes be used to predict transition from normoalbuminuria to microalbuminuria?
    Adler SG; Kang SW; Feld S; Cha DR; Barba L; Striker L; Striker G; Riser BL; LaPage J; Nast CC
    Am J Kidney Dis; 2002 Jul; 40(1):184-8. PubMed ID: 12087577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated ambulatory blood pressure in microalbuminuric IDDM patients is inversely associated with renal plasma flow. A compensatory mechanism?
    Poulsen PL; Juhl B; Ebbehøj E; Klein F; Christiansen C; Mogensen CE
    Diabetes Care; 1997 Mar; 20(3):429-32. PubMed ID: 9051400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.